Cancer is a leading cause of death worldwide, resulting in∼ 10 million deaths in 2020.
Major oncogenic effectors are the Myc proto-oncogene family, which consists of three …

N-myc down-regulated gene 1 (NDRG1) is a known metastasis suppressor in multiple
cancers, being also involved in embryogenesis and development, cell growth and …

The serine synthesis pathway (SSP) involving metabolic enzymes phosphoglycerate
dehydrogenase (PHGDH), phosphoserine aminotransferase 1 (PSAT1), and phosphoserine …

The human genome is mostly transcribed, yielding a rich repository of noncoding transcripts
that are involved in a myriad of biological processes including cancer. However, how many …

[Frontiers in Bioscience E4, 1528-1541, January 1, 2012] 1528 The role of cancer stem cells in
relapse of solid tumors Yang Yu1 Page 1 [Frontiers in Bioscience E4, 1528-1541, January 1 …

Exosomes are cell–cell communicators emerging as a new paradigm for noninvasive
diagnosis and prognosis of treatment response. Exosomal tetraspanin proteins like CD63 …

Breast cancer (BC) is the leading cause of cancer death in women. This disease is
heterogeneous, with clinical subtypes being estrogen receptor-α (ER-α) positive, having …

The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), is negatively
correlated with tumor progression in multiple neoplasms, being a promising new target for …

N-myc downstream-regulated gene 1 (NDRG1) has been reported to act as a key regulatory
molecule in tumor progression-related signaling pathways, especially in tumor metastasis …

N-myc downstream regulated gene 1 (NDRG1) has been well characterised to act as a
metastatic suppressor in a number of human cancers. It has also been implicated to have a …